Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Donovan

Showing results (161-170 of 164) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 164 results.
BMC Public Health|January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trialK S Smith, J M Kaldor, J S Hocking, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
BMC Infectious Diseases|December 14, 2016
A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocolD Callander, M Stoové, A Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin InflammationWei Li, Kimberly K Crouse, Jennifer Alley, et al.
Pageof 17

Showing results (161-170 of 164) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 164 results.
BMC Public Health|January 30, 2016
The acceptability and cost of a home-based chlamydia retesting strategy: findings from the REACT randomised controlled trialK S Smith, J M Kaldor, J S Hocking, et al.
British Journal of Pharmacology|June 18, 1999
UK-78,282, a novel piperidine compound that potently blocks the Kv1.3 voltage-gated potassium channel and inhibits human T cell activationD C Hanson, A Nguyen, R J Mather, et al.
BMC Infectious Diseases|December 14, 2016
A longitudinal cohort study of HIV 'treatment as prevention' in gay, bisexual and other men who have sex with men: the Treatment with Antiretrovirals and their Impact on Positive And Negative men (TAIPAN) study protocolD Callander, M Stoové, A Carr, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 4, 2023
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6<sup>+</sup> T Cells, and Ameliorates Interleukin-23-Induced Skin InflammationWei Li, Kimberly K Crouse, Jennifer Alley, et al.
Pageof 17